Workshop on imaging science development for cancer prevention and preemption Journal Article


Authors: Kelloff, G. J.; Sullivan, D. C.; Baker, H.; Clarke, L. P.; Nordstrom, R.; Tatum, J. L.; Dorfman, G. S.; Jacobs, P.; Berg, C. D.; Pomper, M. G.; Birrer, M. J.; Tempero, M.; Higley, H. R.; Petty, B. G.; Sigman, C. C.; Maley, C.; Sharma, P.; Wax, A.; Ginsberg, G. G.; Dannenberg, A. J.; Hawk, E. T.; Messing, E. M.; Grossman, H. B.; Harisinghani, M.; Bigio, I. J.; Griebel, D.; Henson, D. E.; Fabian, C. J.; Ferrara, K.; Fantini, S.; Schnall, M. D.; Zujewski, J. A.; Hayes, W.; Klein, E. A.; DeMarzo, A.; Ocak, I.; Ketterling, J. A.; Tempany, C.; Shtern, F.; Parnes, H. L.; Gomez, J.; Srivastava, S.; Szabo, E.; Lam, S.; Seibel, E. J.; Massion, P.; McLennan, G.; Cleary, K.; Suh, R.; Burt, R. W.; Pfeiffer, R. M.; Hoffman, J. M.; Roy, H. K.; Wang, T.; Limburg, P. J.; El-Deiry, W. S.; Papadimitrakopoulou, V.; Hittelman, W. N.; MacAulay, C.; Veltri, R. W.; Solomonzz, D.; Jeronimo, J.; Richards-Kortum, R.; Johnson, K. A.; Viner, J. L.; Stratton, S. P.; Rajadhyaksha, M.; Dhawan, A.
Article Title: Workshop on imaging science development for cancer prevention and preemption
Keywords: cancer survival; clinical trial; histopathology; bevacizumab; fluorouracil; cancer risk; nonhuman; capecitabine; paclitaxel; adjuvant therapy; pancreas cancer; drug megadose; nuclear magnetic resonance imaging; positron emission tomography; lymph node metastasis; cancer diagnosis; cancer incidence; diagnostic accuracy; sensitivity and specificity; neoplasms; cancer susceptibility; gene overexpression; bcg vaccine; unindexed drug; cancer prevention; chemoprophylaxis; low drug dose; computer assisted tomography; ovary cancer; breast cancer; gene expression profiling; imiquimod; actinic keratosis; image interpretation, computer-assisted; skin cancer; cancer screening; lung cancer; calcium; molecular imaging; diagnostic imaging; bladder cancer; cetuximab; epiluminescence microscopy; risk assessment; irinotecan; prostate cancer; imaging system; lung metastasis; drug uptake; mammography; computer assisted diagnosis; diagnostic value; head and neck cancer; early cancer; early diagnosis; prostatectomy; genomic instability; contrast enhancement; three dimensional imaging; acetylsalicylic acid; colonoscopy; folinic acid; colon cancer; diclofenac; nonsteroid antiinflammatory agent; proton pump inhibitor; uterine cervix cancer; breast tumor; echography; nuclear magnetic resonance spectroscopy; tamoxifen; chromosomal instability; fluorescence microscopy; alpha tocopherol; selenium; epigallocatechin gallate; immunomodulating agent; letrozole; cystoscopy; gastroesophageal reflux; oxaliplatin; risk reduction; photodynamic therapy; beta carotene; retinoid; phage display; catheter ablation; ultrasmall superparamagnetic iron oxide; endoscopic retrograde cholangiopancreatography; leukoplakia; wart virus; multidetector computed tomography; optical coherence tomography; esophagus biopsy; cryotherapy; photofrin; precancerous conditions; aminolevulinic acid; papanicolaou test; transvaginal echography; barrett esophagus; light scattering; esophagoscopy; microbubble; antimitotic agent; aminolevulinic acid hexyl ester; arzoxifene; resiquimod
Journal Title: Cancer Biomarkers
Volume: 3
Issue: 1
ISSN: 1574-0153
Publisher: IOS Press  
Date Published: 2007-01-01
Start Page: 1
End Page: 33
Language: English
PUBMED: 17655039
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 8" - "Export Date: 17 November 2011" - "Source: Scopus"
Citation Impact
MSK Authors